Related Experiment Videos

Evidence for a function of death-receptor-related, death-domain-containing proteins in anoikis

S M Frisch1

  • 1The Burnham Institute 10901 North Torrey Pines Road, La Jolla, California 92037, USA. sfrisch@burnham-inst.org

Current Biology : CB
|October 6, 1999
PubMed

Insights

Anoikis, a programmed cell death, prevents cancer by triggering apoptosis when cells lose matrix contact. This study reveals death receptors initiate anoikis, offering new therapeutic targets for malignancy.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Normal epithelial cells undergo programmed cell death (apoptosis) when they detach from the extracellular matrix, a process known as anoikis.
  • Anoikis is crucial for tissue organization and preventing cancer metastasis.
  • Resistance to anoikis is a hallmark of malignancy, often linked to oncogenes and tumor suppressor genes.

Purpose of the Study:

  • To investigate the molecular mechanisms initiating anoikis.
  • To test the hypothesis that death receptor activation is involved in triggering anoikis.

Main Methods:

  • Development of a transient assay for anoikis.
  • Assay of proteins that inhibit death domain function, including silencer of death domains (SODD) and dominant-negative FAS-associated death domain protein (FADD).
  • Analysis of caspase 8 activation and its substrate BID cleavage following cell-matrix detachment.

Main Results:

  • SODD and dominant-negative FADD significantly inhibited anoikis in Madin-Darby canine kidney (MDCK) cells.
  • The protective effect of SODD was dependent on its BAG domain, which interacts with heat shock proteins (hsp70 and hsc70).
  • Cell-matrix detachment activated caspase 8 and led to the cleavage of BID, a known substrate of caspase 8.

Conclusions:

  • Death receptors or related death domain proteins play a role in initiating anoikis.
  • Understanding this pathway provides insights into cancer development and potential therapeutic strategies.
  • Targeting death receptor signaling could offer a novel approach to combat anoikis resistance in cancer.

Related Concept Videos